Nuvation Bio, Inc. (NUVB)
Stock Price: $10.03 USD
-0.37 (-3.56%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $9.60 -0.43 (-4.29%) Feb 26, 7:57 PM
| Market Cap | 2.18B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 14.86M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $10.03 |
| Previous Close | $10.40 |
| Change ($) | -0.37 |
| Change (%) | -3.56% |
| Day's Open | 10.40 |
| Day's Range | 9.90 - 10.40 |
| Day's Volume | 606,808 |
| 52-Week Range | 8.56 - 12.52 |
News
Hide News
SAN FRANCISCO--(BUSINESS WIRE)--Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (Fi...
Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp...
About NUVB
There is no company description available.
| CEO Dr. David T. Hung M.D. | |
| Stock Exchange NYSE | Ticker Symbol NUVB |